stockportfolio.pro
Supernus Pharmaceuticals, Inc. Shares Outstanding 2010–2025
Supernus Pharmaceuticals, Inc. (SUPN) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 57.5M | +3.1% |
| FY 2024 | 55.7M | +1.9% |
| FY 2023 | 54.7M | +0.9% |
| FY 2022 | 54.3M | +1.9% |
| FY 2021 | 53.3M | +0.7% |
| FY 2020 | 52.9M | +0.6% |
| FY 2019 | 52.5M | +0.4% |
| FY 2018 | 52.3M | +2.0% |
| FY 2017 | 51.3M | +2.7% |
| FY 2016 | 50.0M | +2.0% |
| FY 2015 | 49.0M | +14.0% |
| FY 2014 | 43.0M | +7.5% |
| FY 2013 | 40.0M | +30.6% |
| FY 2012 | 30.6M | +1742.1% |
| FY 2011 | 1.7M | — |
| FY 2010 | 0.0M | — |
Source: Supernus Pharmaceuticals, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Supernus Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSupernus Pharmaceuticals, Inc. — frequently asked questions
What is Supernus Pharmaceuticals, Inc.'s shares outstanding?
Supernus Pharmaceuticals, Inc. (SUPN) reported shares outstanding of 57.5M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Supernus Pharmaceuticals, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.